🔗 Visit the ClinicalTrials.gov page for NCT04752397
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Scleroderma. | N Engl J Med | 2009 | 6.50 |
| 2 | Overview of pathogenesis of systemic sclerosis. | Rheumatology (Oxford) | 2009 | 1.44 |
| 3 | Guidelines on the use of extracorporeal photopheresis. | J Eur Acad Dermatol Venereol | 2014 | 0.85 |
| 4 | Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. | J Eur Acad Dermatol Venereol | 2003 | 0.78 |
| 5 | An update on biomarker discovery and use in systemic sclerosis. | Expert Rev Mol Diagn | 2017 | 0.75 |
| 6 | IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients. | Clin Exp Immunol | 2017 | 0.75 |
| 7 | Phototherapy in Scleroderma. | Dermatol Ther (Heidelb) | 2016 | 0.75 |
| 8 | Photopheresis: Advances and Use in Systemic Sclerosis. | Curr Rheumatol Rep | 2017 | 0.75 |
| 9 | PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis. | Nat Commun | 2017 | 0.75 |